Table: Hisamitsu -Q1 group results
Jul 10 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
May 31, 2019 May 31, 2018 Feb 29, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 29.23 33.51 143.50
(-12.8 pct) (-7.2 pct) (+0.1 pct)
Operating 2.78 4.36 22.90
(-36.3 pct) (-14.4 pct) (+2.8 pct)
Recurring 2.86 4.45 25.50
(-35.6 pct) (-10.0 pct) (+3.5 pct)
Net 1.91 3.45 19.40
(-44.6 pct) (-6.0 pct) (+1.0 pct)
EPS 23.15 yen 41.27 yen 234.69 yen
EPS Diluted 23.13 yen 41.23 yen
Ann Div 82.50 yen 83.00 yen
-Q2 div 41.25 yen 41.50 yen
-Q4 div 41.25 yen 41.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO